Adamas Pharma (ADMS) Lower on $50M Stock Offering
Tweet
Share
E-mailGet Alerts ADMS Hot Sheet
Join SI Premium – FREE
Adamas Pharma (NASDAQ: ADMS) is lower after the company filed a prospectus covering $50 million in common stock. Shares will be offered through Cowen.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DEFSEC Technologies (DFSC) files for 4.05M share offering by selling stockholders
- California Resources completes $63M acquisition of Crimson Midstream
- Lianhe Sowell prices $11M follow-on stock offering on Nasdaq
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
